A decade after the vote, Brexit's NHS bill comes due
Ten years on from the referendum, the question the Leave campaign put at the centre of the argument is back — and the answer is more uncomfortable than either side wants to admit.
On 23 June 2016, 51.9% of voters in the United Kingdom chose to leave the European Union. The red bus that toured Middle England promised £350m a week for the National Health Service. Ten years on, the NHS is in the middle of its worst funding settlement of the devolved era, and the debate about whether Brexit helped or hurt is, again, a live political argument.
The honest answer, after a decade of data, is that leaving the EU did not break the NHS — but it stripped the health service of several of the workforce and supply pipelines it had quietly relied on, at exactly the moment those pipelines were needed most. That distinction is doing a lot of work in Whitehall this summer, and it deserves more honesty than either Remainers or Leavers are offering.
What the data actually shows
The headline numbers, taken in isolation, are kinder to Leave than the metropolitan commentariat likes to admit. The NHS England budget has risen in cash terms almost every year since 2016. Waiting lists ballooned during the pandemic, but have begun to fall in 2025-26. A&E performance is poor, but comparable to several large EU health systems. The apocalyptic framing — that Brexit would collapse the service within a parliament — has not materialised.
What has materialised is more prosaic and more durable. EU-national staff registrations with the Nursing and Midwifery Council fell sharply after the referendum and never recovered to pre-2016 levels. Mutual recognition of professional qualifications, the mechanism that allowed a Spanish nurse or a Romanian doctor to start work in a London hospital within weeks, was abandoned. The NHS now recruits from a narrower set of countries, mainly the Philippines, India, Nigeria and Ghana — a pipeline that is more expensive per hire, more vulnerable to sudden rule changes in source countries, and more exposed to the small-number risks of any single sending state tightening its emigration rules.
The counter-narrative, and why it doesn't hold
The Leave case, as restated this anniversary week, leans on three pillars: that the NHS has always been mismanaged regardless of EU membership; that leaving the European bloc freed regulatory flexibility on clinical trials and data; and that net migration from outside Europe has more than compensated for the fall in EU arrivals. Each contains a grain of truth and a larger problem.
Yes, the NHS has been chronically mismanaged. That is not new and it is not an argument for or against Brexit. On regulatory flexibility: the UK has indeed used post-Brexit latitude to overhaul clinical trial rules, and the MHRA has approved medicines ahead of the European Medicines Agency on a number of occasions. The trade-off is that the UK now sits outside the EU's joint procurement for vaccines, antivirals and orphan medicines — a position that cost real money during the Covid-19 vaccine rollout and continues to cost leverage in pandemic-preparedness negotiations. On migration: non-EU arrivals have indeed grown, but the integration time, language requirements and visa costs mean the older EU pipeline was structurally cheaper.
The structural frame, in plain prose
The deeper story is about what membership of a continental bloc actually bought a service as labour-intensive as the NHS. The European economic area functioned, for UK health policy, as a cheap, fast recruitment valve. When you close that valve, you do not get a single dramatic rupture. You get a slow, cumulative drag on staffing costs, on locum spend, on agency mark-up, and on the time it takes to fill a rota gap in a district general hospital in Sunderland or Scunthorpe. Over a decade, that drag compounds into the kind of statistics that end up on the front of the Daily Mail in a slow-news week.
The same dynamic applies, less remarked upon, to medical supply chains. Customs paperwork at Dover adds days to the delivery of radioisotopes and certain biological medicines with short half-lives. The UK has built new routes, but a friction-free supply chain is not something you can recreate from scratch with a trade deal. It is the accumulated residue of thirty years of regulatory alignment.
Stakes, and what is actually contestable
The political stakes of this anniversary are tactical rather than strategic. Labour holds a working majority and has no incentive to reopen the Brexit question. The Conservatives are split between a soft-realignment faction that wants a closer Swiss-style relationship with the single market and a harder-line base that views any such move as a betrayal. Reform UK treats the anniversary as a recruiting sergeant.
What is genuinely contestable — and where the evidence is thinnest — is the counterfactual. We do not know what a 2026 NHS inside the EU would look like, and the people who claim to know are mostly selling a position. The honest reading is that membership would have eased two specific pressure points (workforce pipeline, supply chain friction) and done nothing about the structural ones (capital under-investment, social-care bottleneck, an aging demographic curve that no trading arrangement can fix). It is the kind of qualified, unsatisfying verdict that does not fit on a bus.
Ten years on, the NHS is not dying of Brexit. It is, however, paying a quiet, ongoing tax for the decision — and the bill is unlikely to shrink before the next general election.
This publication has covered the post-referendum settlement as a question of institutional plumbing rather than constitutional romance. The story was always about workforce, supply chains and regulatory alignment; it was never about sovereignty in the abstract.